| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
1e-09 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
9e-09 |
| mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-08 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-08 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
| mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
7e-08 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-08 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.18 |
2e-07 |